Dynamics Special Purpose Corp. License Agreements
4 Contracts & Agreements
- Amendment No. 1 to the Research and License Agreement between Spark Therapeutics, Inc. and Senti Biosciences, Inc., dated December 8, 2022 (Filed With SEC on March 22, 2023)
- Patent License Agreement by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, and Senti Biosciences, Inc., dated July... (Filed With SEC on February 14, 2022)
- Patent License Agreement by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, and Senti Biosciences, Inc., dated... (Filed With SEC on February 14, 2022)
- Patent License Agreement by and between the U.S. Department of Health and Human Services, as represented by the National Cancer Institute, and Senti Biosciences, Inc., dated May... (Filed With SEC on February 14, 2022)
